E. A. Ryadinskaya

E. A. Ryadinskaya

Auto-generated profile, based on publicly available information

E. A. Ryadinskaya

The Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 May 2023 in Pediatric Hematology/Oncology and Immunopathology
Verified
Journal Article
Open access
PDF file
ERE. A. Ryadinskaya
E. A. Ryadinskaya
AIA. Yu. Ivanashkin
A. Yu. Ivanashkin
ARA. S. Rybalko
A. S. Rybalko
VLV. V. Lazarev
V. V. Lazarev
IKI. A. Kryukov
I. A. Kryukov
DAD. N. Arzin
D. N. Arzin
The development of modern technologies and an increase in the incidence of severe pediatric acute respiratory distress syndrome in children with oncohematological diseases provide some evidence for the medical society to reconsider the indications for extracorporeal membrane oxygenation in this group of patients. The literature review presents an analysis of recent studies on extracorporeal membrane oxygenation usage in children with oncohematological diseases and after hematopoietic stem cell transplantation. The reviewed studies revealed an improvement of the survival rate among such patients over the last decade.

14 April 2026 in Pediatric Hematology/Oncology and Immunopathology
Verified
Journal Article
Open access
AIA. Y. Ivanashkin
A. Y. Ivanashkin
PDP. E. Dyakonov
P. E. Dyakonov
ERE. A. Ryadinskaya
E. A. Ryadinskaya
IKI. A. Kryukov
I. A. Kryukov
VLV. V. Lazarev
V. V. Lazarev
NGN. S. Grachev
N. S. Grachev
Introduction. Extracorporeal membrane oxygenation (ECMO) is increasingly used in pediatric oncology patients with severe cardiac and/or respiratory failure. However, experience with this technique in this population remains limited, particularly in Russia. Materials and methods. Here we retrospectively reviewed the first 5 cases of peripheral venoarterial ECMO use in children with malignancies (4 females, 1 male) treated at the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology from October 2024 to May 2025. The median age was 12 years. Indications, patient selection criteria, ECMO duration, complications, and outcomes were analyzed. Results. In 4 out of 5 patients, ECMO was initiated due to refractory cardiac and/or respiratory failure, and in 1 case, it was used as intraoperative support. The median ECMO duration was 5 days; the median length of stay at the Intensive Care Unit was 20 days. Four patients were successfully decannulated and subsequently discharged. One patient died due to oxygenator thrombosis. Despite the extreme illness severity at baseline (pSOFA 9, VIS 95, VVR 112), no major infectious or hemorrhagic complications occurred. Conclusion. In this paper, we reported the first Russian experience of ECMO use in children with cancer demonstrating that not only is it in principle possible but also effective, as long as a multidisciplinary approach and strict selection criteria are adopted and a trained team of specialists are on hand.

14 October 2019 in Pediatria. Journal named after G.N. Speransky
Verified
Journal Article
Closed access
ERE.A. Ryadinskaya
E.A. Ryadinskaya
MKM.A. Kosyreva
M.A. Kosyreva
NGN.B. Guseva
N.B. Guseva
AKA.A. Korsunskiy
A.A. Korsunskiy
SOS.B. Orehova
S.B. Orehova
M9Moscow G.N. Speransky City Children’s Hospital No. 9
Moscow G.N. Speransky City Children’s Hospital No. 9
Облако Mail.ru - это ваше персональное надежное хранилище в интернете.